Regulatory and Compliance

Legislation, regulations, enforcement actions, and industry guidelines, at both the federal and state level, can significantly impact both a company’s business operations in the present and its strategic planning for the future. Companies must comply with all of these laws and standards, many of which seemingly conflict simultaneously.

DarrowEverett’s Regulatory and Compliance team advises our clients on the appropriate course of action when navigating challenging government regulations and/or agency actions. We regularly represent our clients before agencies that regulate industries such as cannabis cultivation and distribution, environment, financial services, healthcare, investment management, licensing, pharmaceuticals and nutraceuticals, public utilities, renewable and non-renewable energy, telemarketing and sales, and wireless communications.

The DE Regulatory and Compliance Team provides representation before many government authorities, including:

  • Centers for Medicare and Medicaid Services
  • Consumer Financial Protection Bureau
  • U.S. Drug Enforcement Administration
  • Federal Communications Commission
  • Federal Deposit Insurance Corporation
  • Federal Reserve Board
  • Federal Trade Commission
  • Financial Industry Self-Regulatory Authority
  • Internal Revenue Service
  • National Credit Union Administration
  • Office of the Comptroller of the Currency
  • U.S. Patent and Trademark Office
  • U.S. Securities and Exchange Commission
  • U.S. Food and Drug Administration
  • U.S. Department of Health and Human Services
  • State Attorneys General
  • State Banking Authorities
  • State Cannabis Regulatory Agencies
  • State Departments of Labor
  • State Departments of Revenue
  • State Insurance Regulatory Agencies
  • State Licensing Boards
  • State Securities Regulators

Practice Leaders

Kevin P. Gildea - Of Counsel


Kevin P. Gildea is a member of DarrowEverett’s Corporate & Business Transactions, Healthcare & Life Sciences, Regulatory & Compliance and Data Privacy & Cybersecurity Groups. He has a practice concentrated in the areas of corporate, banking, healthcare and life sciences, renewable energy, non-profit, and financial services regulation, compliance, litigation and enforcement defense, and transaction and merger-acquisition related structuring, domestically and internationally. He has experience defending companies in civil and criminal government investigations and enforcement actions, litigating...

Read more

Beth N. Lowson - Of Counsel


Beth N. Lowson is Of Counsel and a Practice Leader for DarrowEverett’s Regulatory & Compliance, and Private Equity, Capital Markets & Securities Practice Groups, focusing primarily on corporate and securities law. Beth’s clients are in the investment management and financial services sectors and include publicly traded and private companies, hedge funds and other private funds, SEC and state-registered investment advisors, broker-dealers, and private investors. Beth regularly advises clients concerning SEC reporting and compliance, corporate formation...

Read more

Contact our Regulatory and Compliance Group.

Please contact us to let us know how DarrowEverett can serve you.

    DE Insights

    Our team wants you to stay informed about legal and regulatory developments that impact your business.

    Investment Advisors Face Added Regulation That Could Potentially Impact Litigation

    On February 13, 2024, FinCEN issued a Notice of Proposed Rulemaking (NPRM) to deter criminals and foreign adversaries who seek to potentially compromise the U.S. financial system and assets through investment advisors. If passed, the new rule would make investment advisors subject to the Bank Secrecy Act (BSA) by expanding the definition of “financial institution”…
    Read more

    SEC’s New Rules Give SPACs, Target Companies Much to Consider

    On January 24, 2024, the U.S. Securities and Exchange Commission (the “SEC”) adopted new final rules relating to special purpose acquisition companies (“SPACs”). The new rules affect both initial public offerings (“IPOs”) for SPACs and so-called “de-SPAC” transactions involving target companies who enter into a business combination with SPACs. In summary, the new rules appear…
    Read more

    Venture Debt: Down Round Protection Without Triggering Downside Provisions

    There is increasing chatter in the startup and investor space surrounding venture debt. It is not at all surprising that as the availability of ready capital has contracted considerably over the past two years, debt and debt-like items have come to the front of mind. It is tempting to think that it is only venture-backed…
    Read more